Transaction Marks Henry Schein’s Entrance Into World’s 2nd Largest Dental Market
MELVILLE, N.Y., Oct. 19, 2014 /PRNewswire/ — Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has invested in Iwase Dental Supply, Inc., a leading full-service provider of dental consumables, implants and equipment in Japan. The transaction marks Henry Schein’s entrance into Japan, the world’s 2nd largest dental market, and increases to 28 the number of countries in which the Company operates.
Iwase Dental Supply’s existing shareholders, including the Iwase family, will continue to hold the remaining shares of the company. Henry Schein will not be consolidating Iwase’s financial results. Financial and other terms of the transaction were not disclosed. The Company expects the transaction to be neutral to its earnings per share in 2015.
Founded in 1926 with headquarters in Utsunomyia, Japan, Iwase Dental Supply is a privately held company with 240 team members, including 150 sales representatives. Led by Mr. Kenichiro Iwase, the third generation of the Iwase family to lead the company, Iwase Dental Supply reported 2013 sales of $190 million. Mr. Iwase has been named Representative Director and Managing Director of Henry Schein Japan, and will continue to lead Iwase Dental Supply.
“Henry Schein is pleased to enter the world’s 2nd largest dental market alongside such a highly regarded partner as Iwase Dental Supply,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “Building on the strong 89-year heritage of Iwase Dental Supply, we look forward to working with the Iwase family and benefitting from their unique market insights and decades of industry leadership. We believe the Japanese dental market, with an estimated 68,000 practicing dentists serving an aging population and increasing demand for elective dental procedures, will continue to grow in the years to come. With the expertise of Kenichiro Iwase, we expect to pursue additional transactions in the Japanese market and expand our business to meet this anticipated demand.”
Iwase Dental Supply, the third largest dental dealer in Japan, operates one distribution facility and has 14 branch offices serving nine prefectures, including the eight prefectures surrounding Tokyo, as well as Iwate in northern Japan.
“We are pleased to partner with a company similar to Iwase Dental that has been dedicated to serving dental practitioners for more than three quarters of a century,” said Mr. Iwase. “With the global resources that Henry Schein provides, our vision is to build the premiere pan-Japanese oral health distributor and we are eager to find the right strategic partners to make this a reality.”
Henry Schein’s dental business is the leading global distributor of products and services, including innovative digital dental technology solutions, to office-based general dental practitioners, dental specialists and dental laboratories. The Company serves its customers through a multifaceted sales and marketing approach that includes more than 2,600 dedicated dental field sales consultants, as well as product specialists, telesales representatives and direct marketing programs. Henry Schein’s global dental business had 2013 sales of approximately $5 billion.
About Henry Schein, Inc.
Henry Schein, Inc. is the world’s largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein more than17,000 Team Schein Members and serves more than 800,000 customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 28 countries. The Company’s sales reached a record $9.6 billion in 2013, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website at www.henryschein.com.
Cautionary Note Regarding Forward-Looking Statements
In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate” or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the SEC and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.
Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the cost of shipping our products or other service issues with our third-party shippers; general global macro-economic conditions; disruptions in financial markets; possible volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; werfailure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from challenges associated with the emergence of potential increased competition by third party online commerce sites; risks from disruption to our information systems; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority.
We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.
CONTACT: Investors: Steven Paladino, Executive Vice President and Chief Financial Officer, firstname.lastname@example.org, (631) 843-5500; Carolynne Borders, Vice President, Investor Relations, email@example.com, (631) 390-8105; Media: Susan Vassallo, Vice President, Corporate Communications, firstname.lastname@example.org, (631) 843-5562
For Immediate Release
Heraeus Kulzer Acquires Italian CAD/CAM Company EGS Srl
Dental manufacturer expands its product portfolio in digital prosthetics
SOUTH BEND, INDIANA, October 2, 2014 — German dental supplier Heraeus Kulzer GmbH has acquired the Italian CAD/CAM manufacturer Enhanced Geometry Solutions (EGS Srl). Heraeus Kulzer GmbH is the parent company of Heraeus Kulzer, LLC, the worldwide leader in dental esthetics.
EGS is a CAD/CAM company recognized for its leading 3D expertise and technology, targeted at the original equipment manufacturer (OEM) market. Headquartered in Bologna, Italy, EGS distributes its technologies worldwide. With over 15 years of CAD/CAM experience, EGS provides 3D scanners, CAD software and other digital tools for the entire scanning, modeling and designing workflow in dental laboratories. EGS also offers digital solutions in such areas as aerospace, automotive, consumer products and sports.
Heraeus Kulzer, with world headquarters in Hanau, Germany and North American headquarters in South Bend, Indiana, supports dental practices and dental laboratories worldwide with a broad range of products for digital and traditional techniques. The company’s cara® CAD/CAM system, which is not currently available in North America, offers a solution for the complete workflow in digital prosthetics. The range of indications in cara® manufacturing centers extends from milled or sintered crowns and bridges to implant suprastructures and abutments.
As part of Tokyo-based Mitsui Chemicals Inc., Heraeus Kulzer is continuously expanding the group’s international healthcare business. By acquiring EGS, Heraeus Kulzer strengthens its software competence and extends its digital portfolio. “The experts from EGS will significantly strengthen our expertise in the growing area of digitization of the dental value chain”, said Dr. Andreas Bacher, Head of the Digital Services division at Heraeus Kulzer GmbH. “Importantly, this will allow our customers to benefit from enhanced product and services development. In particular, EGS complements and extends the range of our cara® CAD/CAM system offerings with easy-to-use software and scanner modules at attractive prices. This enables us to open up new markets in digital prosthetics to spur both our growth and our ability to support our customers.”
According to Emidio Cennerilli, CEO EGS, “The core competencies and product ranges of Heraeus Kulzer and EGS complement each other very nicely. Our customers in dental labs will benefit enormously from the collaboration between our teams of experts. We trust that both companies’ cultures will foster a strong collaboration leading to expansion of our combined portfolio in the growing digital dental market.”
EGS will continue to operate independently, and all contact persons and programs for the customers of EGS remain unchanged.
About Heraeus Kulzer
Heraeus Kulzer GmbH is one of the world’s leading dental companies with its headquarters in Hanau, Germany. As a trusted partner, the company supplies dentists and dental technicians with an extensive product range, covering cosmetic dentistry, tooth preservation, prosthetics, periodontology and digital dentistry. More than 1,400 employees at 25 locations worldwide are driven by their expertise and passion for the dental market and embody what the name Heraeus Kulzer stands for: service, quality and innovation. In 2013 Heraeus Kulzer’s product turnover exceeded 400 million USD.
Heraeus Kulzer has been part of the Japanese Mitsui Chemicals Group since July 2013. Mitsui Chemicals Inc. (MCI) is based in Tokyo, and has 135 affiliates with more than 14,200 employees in 27 countries worldwide. Its innovative, practical chemical products are as much in demand in the automotive, electronics and packaging industries as they are in other fields such as environmental protection and healthcare.
John Pohl 14th Floor Solutions, LLC 847.812.2879 | email@example.com
An investor group led by Rod Hancock has acquired all of the
assets and business of Engle Dental Systems Inc. effective
September 30, 2014. The new entity, Engle Dental Systems
LLC, will continue to operate from Forest Grove, Oregon and
will pursue a more aggressive sales & marketing campaign to
build the Engle brand. Mr. Hancock, an experienced executive
in the dental industry stated “We are excited to build upon
Engle Dental’s excellent foundation of people and product and
are committed to building the highest quality products to be
sold at an affordable price through our superb distribution
partners. [For any further information please contact Rod
Hancock @ 480-320-960 or email
firstname.lastname@example.org] or visit Engle Dental Systems website
This acquisition puts Danaher’s dental holdings at close to 20 companies. Danaher currently shows 10 on their website – dental business Danaher , however companies such as Dux Dental and Aribex have been roled into other dental business units as brands. Danaher already owns one implant company, Implants Direct and is now set to acquire one of the leading players in the dental implant market, Nobel Biocare.
Check out the details below….
Danaher to acquire Nobel Biocare
Here is the latest M&A event in the dental world. Keystone Industries headquartered in Cherry Hill NJ acquires Bosworth, headquartered in Skokie, IL. Bosworth has been in existence for over 100 years.
Read the rest here…..
Kerr Corporation acquires Dux Dental and Vettec, Inc.
Looks like Danaher has acquired yet another dental company and has made a move into Animal Health with the acquisition of Vettec, Inc.
With the Dux restorative line and infection control line these products will be nice additions. The restorative products such as Zone Temp Cement will fit nicely into Kerr’s portfolio. The infection control products such as Bib-Eze , the disposable bib holder will be a nice addition to the Total Care division.
As far as the Vet side of things , we can only speculate that this will not be the last of Danaher’s acquisitions in Animal Health.
Read the entire story HERE
If you own a small or medium sized dental company or dental practice you probably have some emotional ties to it. Your father or a relative started the business or you personally have grown the business. You may be contemplating selling the business and reaping the rewards of all the years and possibly generations of hard work.
One thing to keep in mind is to try and keep your emotions in check as you get ready to sell and through the sale process.
1. Have realistic expectations about your selling price. Absolutely try and get top dollar for it. Remember that while brand and legacy do have value chances are it has more value to you than to a potential buyer. Present a solid business case as to why your family brand and legacy have value.
2. When it comes to negotiations remember that the business was built to eventually be sold. Sellers can and often do get cold feet during a closing as they second guess if they got the best deal and also what there life will be like after the sale. Make sure you are prepared for life after you sell. Maybe you are an employee, maybe it is a clean break, but whatever the case have a clear personal path prior to closing.
If you can take the emotion out of the sale the process will go much more quickly, smoothly and potentially it will turn out more lucratively for you!
Let us know if we can help,
The Connect the Dents Team
While there is no question that dental M & A activity is increasing “across the board”, there are differences in what the selling price (in terms of PPM — price per multiples) can be depending on the segment the dental company is a part of. In the June 6th Dental Fax Weekly published by The Anaheim Group (subscribe at www.dentalfax.com), the dental segments are currently selling at the highest PPM are software and publishing (approximately 3x on average) while labs are the lowest (0.7). Manufacturing is a solid 2.2x.
M & A Definition: “Trailing Twelve Months” (TTM)
TTM is used in the finance world as a measurement of a company’s financial health. Simply put, it is a calculation of the income for the twelve month period PRIOR to a company report (quarterly or interim). Why is it needed or used? Analysts sometimes want to determine this figure because a partial or interim report doesn’t represent a full year and depending on when during the year the report comes out, the data contained can depict unrepresentative (or “skewed”) numbers (i.e. higher sales at holiday times). To clarify a bit more, relevant to the M & A world, TTM is determined to show either the most recent 12 months of a company’s business or the last 12 months before an event like an acquisition. An example of a formula that is used to determine TTM is:
Most Recent Quarter(s) + Most Recent Year – The Corresponding Quarter(s) 12 Months BEFORE the Most Recent Quarter(s)
Big news today: SEPTODONT TO ACQUIRE TDV
You can read the full press release here: